ANN 0.03% $33.06 ansell limited

Ansell's Pathetic Partnering Relationship with Starpharma in Marketing the Dual Protect Condom

  1. 7,521 Posts.
    lightbulb Created with Sketch. 263
    In late 2014 the TGA approved the selling of the VivaGel condom into Australian market. In early 2015 approval was given for the VivaGel condom to be allowed into New Zealand market

    Ansell also have world rights to market the VivaGel condom under the Dual Protect registration with exception of a few countries

    What a dismal effort by Ansell over this period

    Not only has the marketing of product in Australia been pathetic, but the logistic company for Ansell in New Zealand are not at this current point in time distributing the VivaGel condom

    What does this say for the marketing and management arm at Ansell that is responsible to promote a revolutionary product

    My teenage son could do a better job

    Just yesterday Starpharma announced that it's active ingredient SPL7013 of the Dual Protect Vivagel Condom protects against the Zika Virus

    And how does the PR machine at Ansell respond

    Zero Response

    Wake up Ansell and start to capitalise on a fantastic product
 
watchlist Created with Sketch. Add ANN (ASX) to my watchlist
(20min delay)
Last
$33.06
Change
-0.010(0.03%)
Mkt cap ! $4.584B
Open High Low Value Volume
$33.10 $33.23 $32.90 $279.2K 8.444K

Buyers (Bids)

No. Vol. Price($)
9 99 $33.04
 

Sellers (Offers)

Price($) Vol. No.
$33.06 10 1
View Market Depth
Last trade - 10.19am 29/11/2024 (20 minute delay) ?
ANN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.